AusPAR: Empagliflozin

Australian Public Assessment Report

AusPAR

AusPAR: Empagliflozin [PDF, 1.07 MB]

AusPAR: Empagliflozin [Word, 1.13 MB]

Attachment: Product information: Empagliflozin [PDF, 309.27 KB]

Attachment: Product information: Empagliflozin [Word, 106.64 KB]

Attachment: Extract from the Clinical Evaluation Report: Empagliflozin [PDF, 1.67 MB]

Attachment: Extract from the Clinical Evaluation Report: Empagliflozin [Word, 2 MB]

Device/Product Name

Jardiance

Active ingredients

Empagliflozin

AusPAR Date

27 January 2015

Published

15 March 2015

Submission Number

PM-2013-00674-1-5

Submission Type

New chemical entity

Decision

Approved

This webpage on the TGA website was printed on 12 Sep 2024. Printed content may be out of date. For up-to-date information, always refer to the digital version: https://www.tga.gov.au/resources/auspar/auspar-empagliflozin

Sub menu

AusPAR: Empagliflozin

Help us improve the Therapeutic Goods Administration site